Krystal Biotech, Inc. (KRYS)

268.86 -5.73 (-2.09%) USD  |  NASDAQ  |  Feb 24, 13:47
More

Krystal Biotech Stock Based Compensation (Per Share Quarterly)

Stock Based Compensation (Per Share Quarterly) Chart

View Stock Based Compensation (Per Share Quarterly) for KRYS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Based Compensation (Per Share Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Stock Based Compensation (Per Share Quarterly) Range, Past 5 Years

View Stock Based Compensation (Per Share Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Based Compensation (Per Share Quarterly) Benchmarks

View Stock Based Compensation (Per Share Quarterly) Benchmarks
Start Trial
Amicus Therapeutics, Inc. Upgrade
DexCom, Inc. Upgrade
Alkermes Plc Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade